Objective
This annual conference aims at keeping legal practitioners working with the pharmaceutical sector up-to-date on the latest relevant regulatory developments, legislative initiatives and case law. A particular focus will be on implications for the sector of recent EU activities in the fields of competition law and intellectual property, as well as pharmaceutical law.
Key topics
- Second medical use claims in Europe
- Recent US and EU decisions on Biosimilar and Supplementary Protection Certificates (SPCs)
- Market exclusivity
- Fight against counterfeiting and pharmaceutical crime in the EU
- Data protection and pharmaceutical law
- Recent judgment from the CJEU on parallel imports
- Price containment policies in Member States and early benefit procedures
- Recent activities of the EMA and the European Commission on EU regulatory and pharmaceutical law
Who should attend?
In-house counsel and legal or patent advisers in pharmaceutical companies; lawyers in private practice dealing with pharmaceuticals and medical devices; lawyers in national ministries and authorities dealing with regulation of the sector.
Fees in €:
|
Standard
|
EU and ERA patrons
|
Young lawyers and other groups
|
|
Registration
|
|
|
|
|
|
More details about the fees and discounts
Early registration discount:
10% before 25.01.2016
Discounts available:
25 % - For young lawyers up to 30 years of age (important: the participant must provide a copy or details of his or her passport or identity card on registration); Full-time staff of universities or comparable academic institutions; Staff of charitable organisations or comparable institutions
40 % - Staff of European Union institutions and agencies; Staff of ERA’s patrons (Austria, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Finland, France, Germany and the German states, Greece, Hungary, Ireland, Italy, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Scotland, Slovakia, Slovenia, Spain, Sweden, United Kingdom, City of Trier).